Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice
article
OA: bronze
CC0
⤵ 140 in-corpus citations
AI-generated summary
Endometriotic tissues show altered MMP regulation and progesterone insensitivity, but retinoic acid and TGF-beta restore suppressed MMPs and prevent disease establishment in mice.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
The cyclic expression of matrix metalloproteinases (MMPs) by human endometrium has been suggested to play a role in the invasive process necessary to establish endometriosis. The ability of progesterone exposure to inhibit endometrial MMP-3 and MMP-7 expression requires the local action of TGF beta and may also be linked to the local production of retinoic acid by stromal cells. A continuous expression of several MMPs in endometriotic lesions has been reported, indicating a failure of progesterone or locally produced factors to suppress these enzymes. To address cell-specific MMP regulation associated with endometriosis, we examined expression of MMP-3 and MMP-7 mRNA in eutopic endometrium and endometriotic lesions acquired during the secretory phase of the menstrual cycle. We examined the in vitro regulation of MMP-3 and MMP-7 protein in similar tissues. We also examined the in vitro regulation of MMP secretion by progesterone, retinoic acid, and TGF beta in endometriosis tissues relative to the establishment of experimental disease. Our studies indicate that either eutopic or ectopic tissue from women with endometriosis exhibit patterns of altered MMP regulation in vivo. A lack of responsiveness to progesterone was demonstrated in vitro, associated with a failure to suppress MMP expression and an enhanced ability of the tissue to establish experimental endometriosis. However, in vitro treatments with retinoic acid and TGF beta restored the ability of progesterone to suppress MMPs in vitro and prevented the establishment of experimental disease.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (84)
- Aromatase expression in endometriosis. via openalex
- Deficient 17β-Hydroxysteroid Dehydrogenase Type 2 Expression in Endometriosis: Failure to Metabolize 17β-Estradiol<sup>1</sup> via openalex
- Dominant Expression of Progesterone Receptor Form B mRNA in Ovarian Endometriosis via openalex
- Dysregulated Expression of<i>ebaf</i>, a Novel Molecular Defect in the Endometria of Patients with Infertility<sup>1</sup> via openalex
- Early endometriosis invades the extracellular matrix via openalex
- Early endometriosis invades the extracellular matrix via openalex
- Experimental Endometriosis via openalex
- [Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol]. via openalex
- Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine via openalex
- Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy via openalex
- Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. via openalex
- Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts via openalex
- Localization of Matrix Metalloproteinase-2 in Uterine Endometrium and Ectopic Implants via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Matrix Metalloproteinases and Tace Play A Role in The Pathogenesis of Endometriosis via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Peritoneal endometriosis: Endometrial tissue implantation as its primary etiologic mechanism via openalex
- Progesterone and transforming growth factor-β coordinately regulate suppression of endometrial matrix metalloproteinases in a model of experimental endometriosis via openalex
- Secondary m&#x00FC;llerian system and endometriosis via openalex
- Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. via openalex
- The effect of pregnancy on endometriosis in baboons (Papio anubis, Papio cynocephalus) * via openalex
- The Molecular Basis for Implantation Failure in Endometriosis via openalex
- The Potential Role of Environmental Toxins in the Pathophysiology of Endometriosis via openalex
- Tissue Inhibitor of Metalloproteinase-1 Concentrations are Attenuated in Peritoneal Fluid and Sera of Women with Endometriosis and Restored in Sera by Gonadotropin-Releasing Hormone Agonist Therapy via openalex
- Treatment of Endometriosis via openalex
- W2045487737 via openalex
- W2053321628 via openalex
- W2067997991 via openalex
- W2073595123 via openalex
- W2074260855 via openalex
- W2078698366 via openalex
- W2090413347 via openalex
- W2092174240 via openalex
- W2093303434 via openalex
- W2097246067 via openalex
- W2101314011 via openalex
- W2110828317 via openalex
- W2117243630 via openalex
- W2129260593 via openalex
- W2146000514 via openalex
- W2148050205 via openalex
- W2166070294 via openalex
- W2274786089 via openalex
- W2301406109 via openalex
- W2322133447 via openalex
- W2343832012 via openalex
- W2394593050 via openalex
- W2485351624 via openalex
- W3135921402 via openalex
- W3147297892 via openalex
- W4234393772 via openalex
- W4388182638 via openalex
- W6601959304 via openalex
- W6634728902 via openalex
- W6641761785 via openalex
- W6644465346 via openalex
- W6655832945 via openalex
- W6656356435 via openalex
- W47415772 via openalex
- W6816518819 via openalex
- W83439197 via openalex
- W203933131 via openalex
- W290812845 via openalex
- W1575892319 via openalex
- W1598381272 via openalex
- W1915799065 via openalex
- W1966486298 via openalex
- W1972441006 via openalex
- W1972887139 via openalex
- W1973726394 via openalex
- W1977060444 via openalex
- W1979877257 via openalex
- W1984172347 via openalex
- W1986075242 via openalex
- W1988144057 via openalex
- W1992084421 via openalex
- W2002687754 via openalex
- W2003778314 via openalex
- W2021361522 via openalex
- W2022180080 via openalex
- W2028567925 via openalex
- W2028659031 via openalex
- W2034262035 via openalex
- W2037535156 via openalex
Cited by (50)
- Endometriosis 2025
- WERF Endometriosis Phenome and Biobanking Harmonisation Project for Experimental Models in Endometriosis Research (EPHect-EM-Heterologous): heterologous rodent models 2025
- Unveiling the fibrotic puzzle of endometriosis: An overlooked concern calling for prompt action 2024
- Human Endometrium Derived Mesenchymal Stem Cells with Aberrant NOD1 Expression Are Associated with Ectopic Endometrial Lesion Formation 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 5 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- ERβ-activated LINC01018 promotes endometriosis development by regulating the CDC25C/CDK1/CyclinB1 pathway 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 4 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 3 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 2 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Additional file 6 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Unveiling the fibrotic puzzle of endometriosis: An overlooked concern calling for prompt action 2024
- Additional file 1 of Unraveling pathogenesis, biomarkers and potential therapeutic agents for endometriosis associated with disulfidptosis based on bioinformatics analysis, machine learning and experiment validation 2024
- Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms 2023
- Genome-Wide Gene Expression Profiling Reveals the Direct Effect of Dienogest on Ovarian Endometriotic Stromal Cells 2023
- The landscape of non-coding RNAs in the immunopathogenesis of Endometriosis 2023
- Endometrial Cells Acutely Exposed to Phthalates In Vitro Do Not Phenocopy Endometriosis 2022
- Whole-exome sequencing and functional validation reveal a rare missense variant in <i>MMP7</i> that confers ovarian endometriosis risk 2022
- Unique Sensitivity of Uterine Tissue and the Immune System for Endometriotic Lesion Formation 2021
- Circulating miRNAs Related to Epithelial–Mesenchymal Transitions (EMT) as the New Molecular Markers in Endometriosis 2021
- Steroid hormones regulate genome-wide epigenetic programming and gene transcription in human endometrial cells with marked aberrancies in endometriosis 2020
- Animal models for research on endometriosis 2020
- Dienogest exerts its anti-endometriotic effect throughthe direct suppression of matrix metallopeptidases 2020
- Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure 2020
- Endometriosis Pathogenesis and Management 2019
- The bimodal role of matrix metalloproteinases and their inhibitors in etiology and pathogenesis of endometriosis (Review) 2018
- Physiological and pathological implications of retinoid action in the endometrium 2018
- Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells 2018
- Transcription factor 21 regulates expression of ERβ and SF-1 via upstream stimulatory factor-2 in endometriotic tissues 2018
- Rodent Models of Experimental Endometriosis: Identifying Mechanisms of Disease and Therapeutic Targets 2018
- Weighted Gene Co-expression Network Analysis of Endometriosis and Identification of Functional Modules Associated With Its Main Hallmarks 2018
- Optimization of Endometrial Decidualization in the Menstruating Mouse Model for Preclinical Endometriosis Research 2018
- Influência da doxiciclina em endometriose experimentalmente induzida em ratas 2018
- Increased Expression Levels of Metalloprotease, Tissue Inhibitor of Metalloprotease, Metallothionein, and p63 in Ectopic Endometrium: An Animal Experimental Study 2018
- Progesterone resistance in endometriosis: origins, consequences and interventions 2017
- Early Endometriosis in Females Is Directed by Immune-Mediated Estrogen Receptor α and IL-6 Cross-Talk 2017
- IGF-I stimulates ERβ and aromatase expression via IGF1R/PI3K/AKT-mediated transcriptional activation in endometriosis 2016
- DEVELOPMENT OF A DOMESTIC ANIMAL MODEL OF ENDOMETRIOSIS 2016
- PAI-1 secretion of endometrial and endometriotic cells is Smad2/3- and ERK1/2-dependent and influences cell adhesion 2016
- Epigenetic Modulation of Collagen 1A1: Therapeutic Implications in Fibrosis and Endometriosis1 2016
- Pathogenesis of Endometriosis: Roles of Retinoids and Inflammatory Pathways 2015
- Correlation between dioxin and endometriosis: an epigenetic route to unravel the pathogenesis of the disease 2015
- Endometriosis 2015
- Abundance and Localization of Progesterone Receptor Isoforms in Endometrium in Women With and Without Endometriosis and in Peritoneal and Ovarian Endometriotic Implants 2015
Source provenance
- europepmc
- last seen: 2026-06-16T06:07:01.518242+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:13:01.552487+00:00
License: CC0
· commercial use OK